SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-085104
Filing Date
2023-07-28
Accepted
2023-07-28 08:46:13
Documents
54
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6K azn-20230630x6k.htm   iXBRL 6-K 4559603
7 GRAPHIC azn-20230630x6k001.jpg GRAPHIC 3780
8 GRAPHIC azn-20230630x6k021.jpg GRAPHIC 4829
9 GRAPHIC azn-20230630x6k029.jpg GRAPHIC 5294
  Complete submission text file 0001104659-23-085104.txt   13871725

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA azn-20230630.xsd EX-101.SCH 77691
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE azn-20230630_cal.xml EX-101.CAL 87944
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE azn-20230630_def.xml EX-101.DEF 228103
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE azn-20230630_lab.xml EX-101.LAB 503114
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azn-20230630_pre.xml EX-101.PRE 341767
48 EXTRACTED XBRL INSTANCE DOCUMENT azn-20230630x6k_htm.xml XML 3114699
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-11960 | Film No.: 231120334
SIC: 2834 Pharmaceutical Preparations